Biogen Ma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOGEN MA, and when can generic versions of BIOGEN MA drugs launch?
BIOGEN MA has one approved drug.
There are three US patents protecting BIOGEN MA drugs.
There are forty-six patent family members on BIOGEN MA drugs in twenty-five countries.
Summary for Biogen Ma
International Patents: | 46 |
US Patents: | 3 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Biogen Ma: | See patent lawsuits for Biogen Ma |
PTAB Cases with Biogen Ma as patent owner: | See PTAB cases with Biogen Ma as patent owner |
Drugs and US Patents for Biogen Ma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | 10,385,341 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | 10,669,546 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Biogen Ma | QALSODY | tofersen | SOLUTION;INTRATHECAL | 215887-001 | Apr 25, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Biogen Ma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2019268063 | ⤷ Try a Trial |
Brazil | 112016021848 | ⤷ Try a Trial |
New Zealand | 724100 | ⤷ Try a Trial |
Denmark | 3126499 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.